The protein kinase C-beta inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications.
about
PGC-1α regulation of mitochondrial degeneration in experimental diabetic neuropathy.Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.Postprandial glycemia and cardiovascular disease in diabetes mellitus.Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling.Novel N-pyrimidin-4-yl-3-amino-pyrrolo [3, 4-C] pyrazole derivatives as PKC kinase inhibitors: a patent evaluation of US2015099743 (A1).
P2860
The protein kinase C-beta inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The protein kinase C-beta inhi ...... c microvascular complications.
@ast
The protein kinase C-beta inhi ...... c microvascular complications.
@en
type
label
The protein kinase C-beta inhi ...... c microvascular complications.
@ast
The protein kinase C-beta inhi ...... c microvascular complications.
@en
prefLabel
The protein kinase C-beta inhi ...... c microvascular complications.
@ast
The protein kinase C-beta inhi ...... c microvascular complications.
@en
P2860
P1476
The protein kinase C-beta inhi ...... c microvascular complications.
@en
P2093
Aaron Vinik
P2860
P304
P356
10.1517/13543784.14.12.1547
P407
P577
2005-12-01T00:00:00Z